Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Biliary Tract Cancer Market Growth Evolved From 2024 To 2025, And What’s Ahead?
The market for biliary tract cancer has exhibited significant growth in the past few years. It is projected to expand from $0.67 billion in 2024 to $0.72 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 7.2%. The notable growth during the historic period can be credited to the rising cases of biliary tract cancer, escalating demand for potent therapies, an increase in risk elements like obesity, an aging demographic, and enhanced investment in research and development endeavors.
Anticipated to witness substantial growth in the forthcoming years, the biliary tract cancer market is forecasted to increase to$0.95 billion in 2029 with a compound annual growth rate (CAGR) of 7.1%. Several factors are contributing to this projected growth during the forecast period, such as lifestyle modifications, increased awareness, initiatives for early detection, beneficial reimbursement strategies, and expanding government policies. Technological advancements in diagnosis and treatment methodologies, the embrace of immunotherapy, a surge in demand for precision medicine, modification in treatment strategies, and progress in biomarker-based therapies are among the leading trends observed for this period.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21114&type=smp
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theBiliary Tract Cancer Market?
The escalating cases of obesity are anticipated to fuel the expansion of the biliary tract cancer market. Defined as an excess build-up of body fat that poses a threat to health, obesity is a persistent medical condition. The surge in obesity cases is largely caused by a sedentary lifestyle, psychological influences, age, as well as genetic and biological considerations. Obesity instigates persistent inflammation, insulin resistance, and surplus bile acid secretion which lead to DNA damage and tumor development. Furthermore, it creates imbalance in hormones and metabolism, cultivating a fertile ground for cancer in the biliary tract. As an illustration, the Centers for Disease Control and Prevention, an organisation run by the US government, reported in September 2023 that the number of states with an adult obesity rate of 35% or higher increased to 22 in 2022, a rise from 19 in 2021. Consequently, the upswing in obesity-related cases is contributing to the growth of the biliary tract cancer market.
Which Segments in the Biliary Tract Cancer Offer the Most Growth?
The biliary tract cancermarket covered in this report is segmented –
1) By Cancer Type: Intrahepatic Bile Duct Cancer; Extrahepatic Bile Duct Cancer; Gallbladder Cancer
2) By Treatment: Chemotherapy; Targeted Therapy; Immunotherapy
3) By End-User: Hospitals; Specialty Cancer Centres; Ambulatory Surgical Centres; Other End-Users
Subsegments:
1) By Intrahepatic Bile Duct Cancer: Peripheral Intrahepatic Bile Duct Cancer; Hilar Intrahepatic Bile Duct Cancer
2) By Extrahepatic Bile Duct Cancer: Perihilar Bile Duct Cancer; Distal Bile Duct Cancer
3) By Gallbladder Cancer: Localized Gallbladder Cancer; Advanced Gallbladder Cancer
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21114&type=smp
What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theBiliary Tract Cancer Market?# Market?
North America was the largest region in the biliary tract cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biliary tract cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Current Market Growth and Trends in the Biliary Tract Cancer Industry?
Prominent businesses functioning in the biliary tract cancer market are concentrating on producing enhanced combination treatments to ameliorate efficacy and boost patient results. The term combination therapy illustrates the simultaneous application of two or more drugs or therapeutic methods to cure a single disease. For example, Merck & Co. Inc., headquartered in the US, was granted approval by the U.S. Food and Drug Administration (FDA) in November 2023 for KEYTRUDA (pembrolizumab) to be used in combination with gemcitabine and cisplatin for treating patients with locally advanced unresectable or metastatic biliary tract cancer (BTC). This approval came in light of the outcomes from the Phase 3 KEYNOTE-966 trial, that deduced an impressive improvement in overall survival, lessening the death risk by 17% in comparison to only chemotherapy. The median overall survival for patients on the combination treatment stood at 12.7 months, as opposed to 10.9 months for those only receiving chemotherapy, validating a significant progression in treating this difficult type of cancer.
View the full report here:
https://www.thebusinessresearchcompany.com/report/biliary-tract-cancer-global-market-report
What Are the Key Elements That Define the Biliary Tract Cancer Market?
Biliary tract cancer (BTC), also known as cholangiocarcinoma, is a rare malignancy that arises in the bile ducts, gallbladder, or ampulla of Vater. This cancer disrupts bile flow, which plays a crucial role in digestion and waste elimination. Research and treatment efforts of biliary tract cancer focus on early detection, advancing therapeutic options, and improving survival rates for affected patients.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21114
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model